61 related articles for article (PubMed ID: 15878631)
1. CHART in lung cancer: economic evaluation and incentives for implementation.
Lievens Y; Kesteloot K; Van den Bogaert W
Radiother Oncol; 2005 May; 75(2):171-8. PubMed ID: 15878631
[TBL] [Abstract][Full Text] [Related]
2. Economic consequence of local control with radiotherapy: cost analysis of internal mammary and medial supraclavicular lymph node radiotherapy in breast cancer.
Lievens Y; Kesteloot K; van den Bogaert W
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1122-31. PubMed ID: 16253774
[TBL] [Abstract][Full Text] [Related]
3. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
4. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of proton radiation therapy in the treatment of breast cancer.
Lundkvist J; Ekman M; Ericsson SR; Isacsson U; Jönsson B; Glimelius B
Radiother Oncol; 2005 May; 75(2):179-85. PubMed ID: 15885828
[TBL] [Abstract][Full Text] [Related]
7. Circumferential fusion is dominant over posterolateral fusion in a long-term perspective: cost-utility evaluation of a randomized controlled trial in severe, chronic low back pain.
Soegaard R; Bünger CE; Christiansen T; Høy K; Eiskjaer SP; Christensen FB
Spine (Phila Pa 1976); 2007 Oct; 32(22):2405-14. PubMed ID: 18090078
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of sevelamer in patients with end-stage renal disease.
Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
Hass B; Lungershausen J; Hertel N; Poulsen Nautrup B; Kotowa W; Liedgens H
Eur J Health Econ; 2009 Jul; 10(3):309-21. PubMed ID: 19101743
[TBL] [Abstract][Full Text] [Related]
10. [Incremental cost effectiveness of multifocal cataract surgery].
Pagel N; Dick HB; Krummenauer F
Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
[TBL] [Abstract][Full Text] [Related]
13. [Economic impact of cardiac resynchronization therapy in patients with heart failure. Available evidence and evaluation of the CRT-Eucomed model for analysis of cost-effectiveness].
Fattore G; Landolina M; Bontempi L; Cacciatore G; Curnis A; Gulizia M; Padeletti L; Mazzei L; Tavazzi L;
Ital Heart J Suppl; 2005 Dec; 6(12):796-803. PubMed ID: 16444923
[TBL] [Abstract][Full Text] [Related]
14. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the modifications in the quality assurance system in radiotherapy in the example of in-vivo dosimetry.
Malicki J; Litoborski M; Bogusz-Czerniewicz M; Swiezewski A
Phys Med; 2009 Dec; 25(4):201-6. PubMed ID: 19286407
[TBL] [Abstract][Full Text] [Related]
16. The cost of radiotherapy in a decade of technology evolution.
Van de Werf E; Verstraete J; Lievens Y
Radiother Oncol; 2012 Jan; 102(1):148-53. PubMed ID: 21872955
[TBL] [Abstract][Full Text] [Related]
17. [Selection of clinical evaluation criterion and method of measurement].
Inamura K; Inoue T
Gan To Kagaku Ryoho; 1998 Jan; 25(1):7-12. PubMed ID: 9464323
[TBL] [Abstract][Full Text] [Related]
18. [The cost of radiotherapy].
Martin P
Bull Cancer; 2003 Nov; 90(11):969-75. PubMed ID: 14706900
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness and cost-utility of high-dose palliative radiotherapy for advanced non-small-cell lung cancer.
Coy P; Schaafsma J; Schofield JA
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1025-33. PubMed ID: 11072159
[TBL] [Abstract][Full Text] [Related]
20. [Economic aspects of conformal radiotherapy].
Martin P; Dubray B
Cancer Radiother; 1999; 3(5):437-40. PubMed ID: 10572513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
